Moreover, the stratified analysis from the current meta-analysis suggested that lower adiponectin levels may contribute to an increased T2D risk through pathways independent of other important T2D pathogenic mechanisms such as dyslipidemia and inflammation. The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.